Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Neeta Bahal"'
Publikováno v:
Renal Medicine and Clinical Pharmacy ISBN: 9783030376543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c725157d092c3f16d731192066d528e
https://doi.org/10.1007/978-3-030-37655-0_5
https://doi.org/10.1007/978-3-030-37655-0_5
Autor:
O'Mara, Neeta Bahal1 neetao@aol.com
Publikováno v:
Seminars in Dialysis. Sep/Oct2010, Vol. 23 Issue 5, p475-479. 5p. 1 Chart.
Autor:
O'Mara, Neeta Bahal1, Kapolan, Toros2
Publikováno v:
Formulary. Apr2007, Vol. 42 Issue 4, p233-244. 10p.
Publikováno v:
Annals of Pharmacotherapy. 43:1857-1866
Objective: To evaluate chronic kidney disease (CKD)–associated anemia management challenges and limitations and discuss strategies to improve treatment rates and patient response to therapy, monitoring of patient response to therapy, and education
'This guide is useful for nursing students as well as those in practice.'--Doody's Medical ReviewsThis all-encompassing volume assists nursing students and beginning-level RNs in developing a practical understanding of infection control issues as the
Autor:
Neeta Bahal O'Mara, Milap C. Nahata
Publikováno v:
Journal of Pharmacy Technology. 10:53-57
Objective: To provide a review of the use of parenteral histamine2 (H2)-receptor antagonists cimetidine, ranitidine, and famotidine in the pediatric population. Data Sources: Information was identified by MEDLINE and a review of journals. References
Autor:
Milap C. Nahata, Neeta Bahal
Publikováno v:
Journal of Liquid Chromatography. 16:1135-1142
Phenytoin is used in the prevention and treatment of seizures. It is important to measure the concentrations of both phenytoin and its major metabolite, 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) to fully describe the pharmacokinetics of phenytoi
Autor:
Neeta Bahal, O'Mara
Publikováno v:
Seminars in dialysis. 23(5)
Autor:
Neeta Bahal, Milap C. Nahata
Publikováno v:
Annals of Pharmacotherapy. 26:46-55
OBJECTIVE: To review the chemistry, antimicrobial spectrum, pharmacokinetics, clinical trials, adverse effects, and drug interactions of four new macrolide antibiotics: Azithromycin, clarithromycin, dirithromycin, and roxithromycin. DATA SOURCES: Inf